pMSCV-BirA-P2A-mCherry Citations (4)
Originally described in: Identification of Novel Nuclear Factor of Activated T Cells (NFAT)-Associated Proteins in T cells.Gabriel CH, Gross F, Karl M, Stephanowitz H, Hennig AF, Weber M, Gryzik S, Bachmann I, Hecklau K, Wienands J, Schuchhardt J, Herzel H, Radbruch A, Krause E, Baumgrass R J Biol Chem. 2016 Sep 16. pii: jbc.M116.739326. PubMed Journal
Articles Citing pMSCV-BirA-P2A-mCherry
| Articles |
|---|
| Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity. Zhao H, Liu Y, Wang L, Jin G, Zhao X, Xu J, Zhang G, Ma Y, Yin N, Peng M. Cell Rep. 2021 Dec 7;37(10):110083. doi: 10.1016/j.celrep.2021.110083. PubMed |
| Induction of immortal-like and functional CAR T cells by defined factors. Wang L, Jin G, Zhou Q, Liu Y, Zhao X, Li Z, Yin N, Peng M. J Exp Med. 2024 May 6;221(5):e20232368. doi: 10.1084/jem.20232368. Epub 2024 Mar 26. PubMed |
| GD2T(IF) cells as a platform for single-dose and long-term delivery of biologics. Zhang G, Yin N, Peng M. Nat Commun. 2025 Aug 29;16(1):8088. doi: 10.1038/s41467-025-63427-w. PubMed |
| The transcription factor NFIL3 drives innate lymphoid cell specification from lymphoid progenitors. Leger J, Artano E, Coulais D, Belletoise N, Fadhloun R, Kenney D, Bhandoola A, Harly C. Immunity. 2025 Nov 11;58(11):2685-2703.e6. doi: 10.1016/j.immuni.2025.10.005. Epub 2025 Oct 30. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.